Blogs

Be the first person to recommend this.
ASTCT, along with 20 other organizations and institutions, signed a letter to the Department of Health and Human Services this week, urging officials to ensure the on-time delivery of absolutely essential, life-saving therapies to those most in need during this unprecedented worldwide crisis... Click here to read more
0 comments
Be the first person to recommend this.
The emergence of coronavirus disease 2019 (COVID-19) in Wuhan, China in December 2019 and its rapid evolution into a pandemic is a serious threat to the global social and economic order. This novel virus has caused a healthcare crisis, the likes of which, are not known to our generation... Click here to read more
0 comments
Be the first person to recommend this.
The U.S. Food and Drug Administration (FDA) announced on March 24th that it will allow physicians to use convalescent plasma collected from recovered COVID-19 patients in patients with serious or immediately life-threatening COVID-19 infections. This will be through the process of single patient emergency Investigational New Drug Applications (eINDs) for Individual patients under 21 CFR 312.310.  At the same time, the state of New York announced initiation of a clinical trial using blood plasma from patients who have recovered from COVID-19
0 comments
Be the first person to recommend this.
On Monday, leaders from ASTCT sent a letter to several members of Congress, urging them to to ensure the implementation of the Defence Production Act (DPA) to manufacture of necessary medical equipment to combat COVID-19. Click here to read more
0 comments
Be the first person to recommend this.
The ASTCT Executive Committee has been focused on the impact of COVID-19 on transplantation and cellular therapy patients.  We are working with our partner organizations and BMT centers to promote and share information that is critical to our members and their patients... Click here to read more
0 comments
Be the first person to recommend this.
The federal government is currently taking a number of measures in response to the COVID-19 pandemic. As of March 13, 2020 the President of the United States issued a  proclamation  on declaring a national emergency concern on the coronavirus outbreak. The national emergency announcement includes suspension of entry to foreign nationals into the United States who have been in specific jurisdictions where the virus has been prominent. A governmental task force led by VP Mike Pence has been created in response to the outbreak and is made up of the Administration. Additionally, there has been the  first testing  of a corona virus vaccine. More information from ...
0 comments

NUCLEUS: Presidents Update

Be the first person to recommend this.
Right now, the world is facing an unprecedented crisis. COVID-19 presents unique challenges for people of all walks of life, but especially for healthcare workers. During this time, it is critically important to remain calm and safe. First and foremost, I encourage everyone to review the Centers for Disease Control and Prevention’s guidelines for healthcare workers. This is a comprehensive resource that answers a lot of questions—including what to do if there is someone with the virus at your hospital or cancer center. While we move full steam ahead in our own workplaces, let’s ensure we’re doing our best to be communicative, empathetic and transparent with ...
0 comments
Be the first person to recommend this.
Details forthcoming...  COVID-19_Interim_Patient_Guidelines_3_9_20.pdf
0 comments
Be the first person to recommend this.
In this month’s Pharmacy SIG Literature Update:  PTCy versus ATG for GVHD prophylaxis, cost and outcomes with once-daily busulfan dosing, carfilzomib for the treatment of chronic GVHD and much more! Literature summaries are provided as information only. Please refer to the original published articles for complete details on study methodology, results and discussion. ***        Must read. Landmark publication that affects practice **           Recommend reading. Secondary paper that adds to literature *             Consider reading. Cursory importance to the practice Allogeneic Transplantation **Alatrash G, Kidwell KM, Thall PF, et al.  Reduced ...
0 comments
Be the first person to recommend this.
Please join us for the ASTCT Pharmacy SIG November Journal Club on PD-1 Blockade post HSCT and the Dosing of Conditioning Regimens in Obese Patients on Wednesday, Nov. 20, 2019 at 2:00 pm CST. Our presenters are: Gretchen Junker, PharmD , PGY2 Oncology Pharmacy Resident Kansas University PD-1 Blockade with Pembrolizumab after HSCT Joseph Bubalo, PharmD, BCPS, BCOP, Clinical Pharmacy Specialist Oregon Health and Science University Hospital and Clinics Effect of Conditioning Regimen Dose Reduction in Obese Patients This event is open to all healthcare professionals.  Please register for the event at https://attendee.gotowebinar.com/register/2697968838478151181 ...
0 comments
Be the first person to recommend this.
Since ASTCT’s founding in 1993, one of the most important aspects of the society has been connectivity. In the 25+ years since, we’ve seen the society grow and change. But one thing remains true: the society’s dedication to helping those in BMT and cellular therapy grow as individuals and institutions. ASTCT is made up of 2,200 physicians, investigators, and other health care professionals focused on the advancement of transplantation and cellular therapy. The society offers educational opportunities for everyone—from the fellow who is just beginning his or her career to the seasoned professional—and allows people from all areas of BMT and cellular therapy ...
0 comments
Be the first person to recommend this.
When Dr. John DiPersio looked around at his colleagues—people who were integral parts of the cellular therapy and BMT team, ranging from nurses and PAs to physicians—he realized something that concerned him: Not all were members of ASTCT. The former ASTCT president—and deputy director of the Siteman Cancer Center and professor in medicine in the Department of Medicine, Oncology Division at Washington University School of Medicine in St. Louis—wanted to change that. He knew that everyone could benefit from having an ASTCT membership, but also understood not everyone could afford the individual costs. “We have this entity that is dedicated to cellular therapy ...
0 comments
Be the first person to recommend this.
Mikaela VanMoorleghem, Education and Training Coordinator Foundation for the Accreditation of Cellular Therapy Data Audit Policy Update FACT-JACIE Standards for Hematopoietic Cellular Therapy require that accredited clinical programs keep complete and accurate data, including all data necessary to complete the Transplant Essential Data Forms of the CIBMTR or the Minimum Essential Data-A forms of EBMT. In August 2016, FACT and CIBMTR announced their collaborative program of data auditing, designed to reduce duplicative efforts, enhance quality improvement efforts, and provide support to accredited programs. Over the past three years, the FACT-CIBMTR ...
0 comments
Be the first person to recommend this.
Drug Pricing Legislation Drug pricing legislation has continued to progress in the 116 th Congress as the end of the year draws near. The Administration has made a strong push for drug pricing legislation to be passed in 2019. In May 2018, President Trump’s Administration laid out its Drug Pricing Blueprint , which put forth a number of different policy ideas on how to lower the cost of prescription medication. The suggestions included, drug importation, the International Pricing Index, value based purchasing and Medicare program redesign. With the end of the Congressional year quickly approaching, there is pressure from the Administration to get legislation ...
0 comments
Be the first person to recommend this.
ASTCT is calling for nominations to the Board of Directors, and there could not be a more exciting and rewarding time to get involved! The members of the ASTCT Board of Directors work diligently throughout the year to identify and implement strategy to strengthen our society and the blood and marrow transplantation and cellular therapy community. The enthusiasm, excitement, spirit of collaboration, and professional camaraderie associated with the advancement of our society is truly contagious. We have come so far—and talented and spirited leaders are needed to ensure that we continue to make progress. Serving on the Board offers a tremendous opportunity to make ...
0 comments
Be the first person to recommend this.
It didn’t matter how much training Naoto T. Ueno had, how many patients he had seen in his lifetime and how many medical books he had read. When he was sitting there on the other side of the table—as a patient and not as a doctor—nothing seemed to prepare him for how he felt. “I was scared,” said Ueno, MD, PhD, FACP. “I thought, ‘Am I going to die?’ and if I did, was it going to be slow or fast? When I was working I tried to stop worrying about it, but at home with my family, I was like ‘I can’t think about the future. I can’t visualize myself five years from now.’”   In 2008, Ueno—a world-renowned breast cancer doctor and researcher at The University of ...
0 comments
Be the first person to recommend this.
In this month’s Pharmacy SIG Literature Update: Cryotherapy as prophylaxis against oral mucositis, CD19 CAR T cells in non-Hodgkin lymphoma, risk of latent tuberculosis reactivation after HCT, fertility preservation in HCT patients and much more! Literature summaries are provided as information only. Please refer to the original published articles for complete details on study methodology, results and discussion. ***        Must read. Landmark publication that affects practice **           Recommend reading. Secondary paper that adds to literature *             Consider reading. Cursory importance to the practice Allogeneic Transplantation ...
0 comments
Be the first person to recommend this.
By Mikaela VanMoorleghem, FACT Education and Training Coordinator FACT Announces Events at the 2020 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR  Cellular Therapy Inspection and Accreditation Workshop – February 18 We invite you to join us for upcoming FACT events at the 2020 TCT Meetings!  FACT will conduct a Cellular Therapy Inspection & Accreditation workshop on February 18, 2019, at the World Center Marriott in Orlando, Florida. This workshop will provide an immersive experience for personnel preparing for the accreditation process and a full day training session for FACT inspector trainees. Register for ...
0 comments
Be the first person to recommend this.
On September 27, 2019 ASTCT submitted its comments to CMS on the CY2020 Hospital Outpatient Prospective Payment System Proposed Rule. The proposed rule was released on July 29, 2019. The proposed rule follows the directives from the Presidential Executive Order (EO) entitled “Improving Price and Quality Transparency in American Healthcare to Put Patients First.” According to CMS’ press release the EO, “lay[s] the foundation for a patient-driven healthcare system by making prices for items and services provided by all hospitals in the United States more transparent for patients so that they can be more informed about what they might pay for hospital items ...
0 comments
Be the first person to recommend this.
On August 2, the Centers for Medicare & Medicaid (CMS) released the FY2020 Inpatient Prospective Payment System (IPPS) final rule that includes payment policy for chimeric antigen receptor T-cell (CAR-T) therapy. The American Society for Transplantation and Cellular Therapy (ASTCT) has been working closely with CMS to improve reimbursement for CAR-T therapy and the data the agency collects on its delivery to assure appropriate patient access to this lifesaving therapy. Despite our advocacy efforts, ASTCT is disappointed in the agency’s final payment policy as it did not significantly improve the payment policy for FY 2020 nor did it position the agency ...
0 comments